Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report
- PMID: 28482919
- PMCID: PMC5422897
- DOI: 10.1186/s13256-017-1286-3
Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report
Abstract
Background: Langerhans cell histiocytosis is a sporadic disease caused by an uncontrolled pathogenic clonal proliferation of dendritic cells that have Langerhans cell characteristics. New treatment protocols provided by the HISTSOC-LCH-III (NCT00276757) trial show an improvement in the survival of children with langerhans cell histiocytosis.
Case presentation: We report a case of Langerhans cell histiocytosis, which presented as an osteolytic lesion of the left pre-maxillae enclosing the deciduous incisor and canine in a 7-month-old white Italian boy. He was treated with chemotherapy. He achieved complete remission after 7 months and after 24 months no signs of recurrence were observed.
Conclusions: As a result of this treatment, anesthetic sequelae and loss of teeth were avoided; in addition, we prevented a loss of the vertical dimension of occlusion.
Keywords: Case report; Chemotherapy treatment; Children; Langerhans cell histiocytosis.
Figures
References
-
- PDQ Pediatric Treatment Editorial Board . PDQ Cancer Information Summaries. Bethesda: National Cancer Institute; 2002. Langerhans Cell Histiocytosis Treatment (PDQ®): Health Professional Version. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
